The Guidelines Group remains active, and continues to work closely with Myeloma UK in the development of guidelines and position statements. Recent publications produced by the Group include:
- Screening and Management of Late and Long Term Consequences of Myeloma and its Treatment (British Journal of Haematology 2017 and BSH web site).
- Use of Imaging in the Management of Patients with Myeloma (British Journal of Haematology 2017 and BSH web site).
Current work plans
The UKMF Guidelines Group is currently working on 2 new UKMF/BSH guidelines relating to the treatment of myeloma; one will centre on the treatment of newly diagnosed patients and the other will describe the treatment of relapsed and refractory patients. There are separate writing groups for each guideline, and good progress has been made towards publication.
Plans are also in place to produce UKMF Good Practice Papers (GPPs) on the investigation and management of both the monoclonal gammopathy of undetermined significance (MGUS) and the monoclonal gammopathy of renal significance (MGRS). Work on these GPPs has begun within the last year.
Dr Simon Stern
Chair of UKMF Guidelines Group